Patients n | 80 |
Male sex | 36 (45.0%) |
Age, years | 58 (50–67) |
BMI, kg·m−2 | 27.1 (24.1–32.2) |
BMI ≥30 kg·m−2 | 28 (35.0%) |
Smoking history, pack-years | 11.5 (4.3–25.8) |
Atopic dermatitis | 9 (11.3%) |
Chronic rhinosinusitis with nasal polyps | 4 (5.0%) |
Mepolizumab | 36 (45.0%) |
Benralizumab | 27 (33.7%) |
Dupilumab | 17 (21.3%) |